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Abstract: The group of spinocerebellar ataxias (SCAs) includes more than 20 subgroups
based only on genetic research. The “ataxia genes” are autosomal; the “disease-alleles” are
dominant, and many of them, but not all, encode a protein with an abnormally long
polyglutamine domain. In DNA, this domain can be detected as an elongated CAG repeat
region, which is the basis of genetic diagnostics. The polyglutamine tails often tend to aggregate
and form inclusions. In some cases, protein–protein interactions are the key to understanding
the disease. Protein partners of ataxia proteins include phosphatases and components of
chromatin and the transcriptional machinery. To date, investigation of spinocerebellar ataxias
involves population genetics, molecular methods, and studying model organisms. However,
there is still no efficient therapy for patients. Here, we review the genetic and molecular data
gained on spinocerebellar ataxias.
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Introduction
Spinocerebellar ataxias are late-onset, progressive neurodegenerative, and movement
disorders showing autosomal inheritance. The clinical features of spinocerebellar
ataxias include ataxia, dysarthria, dysmetria, and intention tremor. These types of
diseases (autosomal dominant cerebellar ataxias, ADCAs) are very heterogeneous.
The original classification is based on associated clinical symptoms, such as brain
stem signs and retinopathy. The presence of pyramidal and extrapyramidal symptoms
and ophthalmoplegia points to the diagnosis of ADCA I; the presence of retinopathy,
to ADCA II; and the absence of associated signs, to ADCA III. The new categorization
is based on the latest genetic results, which prove that mutations in more than 20
genes are responsible for these complex phenotypes, and even the clinical subgroups
are genetically heterogeneous.
Spinocerebellar ataxias are not frequent diseases. Prevalence of the autosomal
dominant cerebellar ataxias is estimated to be 3/100 000 in the Netherlands (van de
Warrenburg et al 2002). Frequencies of the different types of ataxias may vary among
regions and ethnic groups. For example, SCA2 is common in Korea, and SCA3 is
much more common in Japan and Germany than in the United Kingdom (Leggo et al
1997; Schols et al 1997; Watanabe et al 1998; Kim et al 2001; Silveira et al 2002).
In the case of ataxias, mutations in completely unrelated genes cause very similar
phenotypes. The source of the mutation in many genetic subtypes of ataxias (SCA1,
SCA2, SCA3, SCA6, SCA7, SCA12, and SCA17) is the same (CAG repeat
expansion), and the resulting protein product contains a long polyglutamine domain.
Some types of ataxias show a partly different molecular background (eg, SCA8,
SCA10, SCA12, and some forms of SCA6), since they involve repeats (not necessarily
CAG) that are not translated, or they do not involve repeats at all. The mutant allele
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responsible for SCA8 codes for a non-coding RNA product,
which can associate with RNA-binding proteins like staufen
in Drosophila melanogaster causing neurodegeneration
(Mutsuddi et al 2004). Disease alleles in the case of SCA10
show massive expansion (800–4500 repeats) of a
pentanucleotide (ATTCT) and not a trinucleotide repeat in
an intron of a gene with unknown function (Matsuura et al
2000). SCA12 is caused by a CAG repeat expansion that is
not transcribed to polyglutamine and is speculated to affect
the expression of the gene PPP2R2B, which encodes a brain-
specific regulatory subunit of protein phosphatase PP2A
(Holmes et al 1999). Although SCA6 is associated with small
expansions of a CAG repeat at the 3´ end of the CACNA1A
gene, which codes for the pore-forming subunit of calcium
channel type P/Q, point mutations in the same gene are
responsible for its two allelic disorders (episodic ataxia
type 2 and familial hemiplegic migraine) (Mantuano et al
2003). There have been many investigations on the role of
molecularly different alleles in causing ataxia. To date, many
SCA alleles are well characterized, and although many do
not involve repeats, one popular field of study in the genetics
of ataxias is the description of repeat-expansion alleles and
the mechanism of their function.
Trinucleotide repeat as a cause of
disease
The CAG/CTG repeat in genes is often translated to a
polyglutamine domain in proteins. Elongated repeat regions
result in elongated polyglutamine tracts. The first protein
proven to be involved in neurodegenerative disorders and
contain an elongated polyglutamine domain was huntingtin,
the factor responsible for Huntington’s disease (HD)
(Huntington’s Disease Collaborative Research Group 1993).
To date, besides HD, nine polyglutamine disorders have been
characterized, including spinobulbar muscular atrophy
(SBMA), dentatorubral-pallidoluysian atrophy (DRPLA),
and spinocerebellar ataxias (SCA) 1, 2, 3, 6, 7, and 17.
Expansion of the CAG/CTG repeats results in alleles which
are genetically dominant because of their toxic gain-of-
function characteristics.
Expansion alleles are polymorphic in populations, and
under a certain repeat number the CAG repeat length should
be considered normal. Alleles carrying intermediate numbers
of repeats are risk alleles for late-onset spinocerebellar ataxia
(see Table 1 for normal and abnormal repeat numbers in
certain types of ataxias). In general, the more repeats, the
earlier the onset of the disease.
Furthermore, there is a genetic phenomenon in relation
to these repeat expansion alleles, called anticipation. The
CAG/CTG repeat sequence is particularly unstable, and de
novo mutations can occur during paternal transmissions of
intermediate-size alleles. The disease increases in severity
in successive generations, and children can have a more
severe form, an earlier onset, or a more rapid progression
of the disease than their parents. In some ataxias, anticipation
may be so extreme that children with an early onset, severe
disease may die of disease complications long before the
affected parent or grandparent is symptomatic.
In the SCA8 ataxia syndrome, the characteristics of
anticipation are unique, since SCA8 is characterized by
dramatic repeat instability and a high degree of reduced
penetrance. In SCA8, the genetic cause of the disease is a
repeat of the CTG trinucleotide instead of CAG. In SCA8,
the majority of expansions of CTG repeat occur during
maternal (and not the usual paternal) transmission, and
extremely large repeats (800 bp) may be associated with an
absence of clinical symptoms (Ranum et al 1999).
Anticipation seems to be dependent on the genomic
context. Transgenic mice carrying cDNA constructs of SCA7
show little intergenerational repeat instability, while in mice
carrying the SCA7 genomic fragment, expansion of the CAG
Table 1 Type and number of repeats belonging to normal, risk,
and disease alleles in different types of spinocerebellar ataxias
Repeat Intermediate Abnormal
Disease type/normal repeat repeat
name number number number
SCA1 CAG/6–44 36–38 39–91
SCA2 CAG/max 31 – 32–500+
SCA3 CAG/max 47 48–51 53–86
S C A 4 –––
S C A 5 –––
SCA6 CAG/max 18 19 19–33
SCA7 CAG/ 7–35 28–35 36–300+
SCA8 CAG/15–50 50–70 71–800+
S C A 9 –––
SCA10 ATTCT/10–22 – 280–4500+
SCA11 – – –
SCA12 CAG/7–31 (45) – 55–78
SCA13 – – –
SCA14 – – –
SCA15 – – –
SCA16 – – –
SCA17 CAG/25–42 42–44 46–63
SCA18 – – –
SCA19 – – –
SCA20 – – –
SCA21 – – –
SCA22 – – –
SCA25 – – –Neuropsychiatric Disease and Treatment 2005:1(2) 127
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repeat can be observed. Deletion of the 3´ genomic region
significantly stabilizes the repeat length in intergenerational
transmission of the genomic construct (Libby et al 2003).
There are other factors which seem to play a role in repeat
stabilization. There are indications that, at least in the case
of some ataxia genes, interruptions in the repeat region can
stabilize the CAG repeat, while lack of interruptive
sequences predisposes alleles towards instability and
expansion. In the case of SCA2, interruptions by CAA
trinucleotides at the 5´ end have such an effect (Choudhry
et al 2001). In some cases, contraction of the repeat region
can also be observed, indicating that repeat length alterations
are dynamic in these types of disorders (Andres et al 2003).
The investigation of CAG repeat length instability in
transgenic mice led to the observation that advanced
maternal age is an important factor for instability of
nucleotide repeats during transmission. If the transgene is
maternally transmitted, the instability occurs after meiotic
DNA replication and prior to oocyte fertilization (Kaytor et
al 1997). However, most of the SCA genes show paternal
anticipation.
A recent publication implies that anticipation of repeats
can be a result of the dysfunction of the DNA repair system
(Lahiri et al 2004). The authors observed that expanded CAG
repeats activate the DNA damage checkpoint pathway in
yeast, and mutation of genes in the pathway can increase
repeat fragility.
How the expanded polyglutamine chain exerts its effect
is not completely clear. Proteins with long polyglutamine
tracts have an increased tendency to aggregate, often as
truncated fragments forming ubiquitinated intranuclear
inclusion bodies. In some cases, like in the case of ataxin-3
(SCA3), cleavage of the polyglutamine chain promotes
aggregation (Paulson et al 1997). The factor responsible for
cleaving the polyglutamine proteins might be different in
different types of ataxias. This would give a reason for the
specific neurotoxic effect of the different ataxia-related
genes. It would be practical to find the proteases that do the
cleavage in the case of the certain elongated ataxia proteins.
The inhibition of the adequate protease might have a
therapeutic effect by reducing the tendency of polyglutamine
domains to aggregate.
An interesting observation proves that CAG repeat
elongation alone is not sufficient to induce the disease. In
the case of SCA1, the S776 amino acid is critical in disease
development: when changed to A776 the induction of the
disease is significantly reduced in transgenic mice, very
likely due to lack of phosphorylation at the 776 position in
ataxin-1 (Emamian et al 2003). These results suggest that
polyglutamine disorders cannot only be explained by
aspecific interactions of the elongated domain.
Genes responsible for
spinocerebellar ataxias
Molecular information, except for chromosomal position,
is not available on most of the SCA genes, but the research
efforts in this field are increasing exponentially. In the
following sections we summarize the information already
gained about the most intensively studied ataxia genes (see
Table 2 for summarized molecular details). We focus only
on the genes for which molecular function was investigated.
SCA1
Using recombination fraction analysis, linkage of SCA1 to
HLA on chromosome 6 (Jackson et al 1977) was shown.
Further studies helped to determine the exact position of
the gene (Kwiatkowski et al 1993; Lunkes et al 1994). The
basic genetic defect in spinocerebellar ataxia-1 consists of
expansion of a trinucleotide CAG repeat (Orr et al 1993) in
a gene termed ataxin-1 that encodes a 10-kb mRNA
transcript (Banfi et al 1994). This was the fifth example of a
pathologic state resulting from expansion of an unstable
trinucleotide repeat. The expanded SCA1 alleles are also
translated into proteins of apparently normal stability and
distribution (Servadio et al 1995).
Human SCA1 with expanded CAG repeats expressed in
Purkinje cells of transgenic mice are sufficient to produce
degeneration and ataxia (Burright et al 1995). Although
nuclear localization of ataxin-1 is necessary for the
development of the disease, nuclear aggregation of ataxin-
1 is not required to initiate pathogenesis in transgenic mice
(Klement et al 1998).
One key to understanding the mechanism of the disease
caused by the mutant ataxin-1 is its interaction with LANP
(leucine-rich acidic nuclear protein). LANP is expressed
predominantly in Purkinje cells, and its interaction with
ataxin-1 is significantly stronger when the number of
glutamines is increased (Matilla et al 1997).
Proteases and chaperons in interaction with ataxia-
related proteins seem to play important roles in ataxias.
Cummings et al (1998) found colocalization of the 20S
proteosome and chaperone HSJ2, a member of the Hsp40
family, with large nuclear inclusions of ataxin-1 in brain
neurons of patients with SCA1 and in mice transgenic for a
mutant SCA1 allele containing 82 glutamines. In theseNeuropsychiatric Disease and Treatment 2005:1(2) 128
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nuclear inclusions, there is also faint staining for Hsc70, a
member of the Hsp70 chaperone family. Similar
colocalization can be seen in HeLa cells transfected with
ataxin-1. In the transfected HeLa cells, unlike in the brain,
there is apparent induction of Hsc70 chaperone.
Overexpression of HSJ2 in these cells reduces aggregation
of ataxin-1, suggesting a possible therapeutic strategy.
In SCA1 mice crossbred with mice overexpressing the
molecular chaperone inducible HSP70, the amount of
nuclear inclusions in Purkinje cells persist, but physiologic
and histopathologic analysis reveals that high levels of
HSP70 protect against neurodegeneration and preserve
dendritic arborization in the cerebellum (Cummings et al
2001).
Latest results demonstrate that ataxin-1 interacts with
the transcriptional corepressor SMRT (silencing mediator
of retinoid and thyroid hormone receptors) and with histone
deacetylase 3. Ataxin-1 binds chromosomes and mediates
transcriptional repression when tethered to DNA. In
Drosophila, genetic interaction between ataxin-1 and
SMRTER (the Drosophila cognate of SMRT) can be observed
(Tsai et al 2004).
SCA2
After determining the exact position of the gene responsible
for SCA2, CAG repeats have been proven to have a major
role in development of the disorder (Pulst et al 1993).
Mice expressing ataxin-2 showed functional progressive
deficits accompanied with the final loss of Purkinje cells
resulting from aggregation in cytoplasm. Despite many
similarities to ataxin-3, ataxin-2 does not form inclusions
in the nucleus and does not gain detectable ubiquitination
(Huynh et al 2000). The expanded form of SCA2 disrupts
the structure of the Golgi apparatus, which is the
predominant location of the normal protein (Huynh et al
2003).
Datx2, the Drosophila homolog of human SCA2, is a
dosage-sensitive regulator of actin filament formation
(Satterfield et al 2002).
SCA3
SCA3 was described in descendants of William Machado,
a native of an island in the Portuguese Azores. This ataxia
is the most frequent one among Portuguese immigrants
living in New England (Nakano et al 1972). The disorder
Table 2 Chromosomal localization and protein products of genes involved in spinocerebellar ataxias
Disease
name Gene Locus Product Inclusions
SCA1 SCA1 6p23 Ataxin-1 Nuclear inclusions in Purkinje cells containing Hsc 70
SCA2 SCA2 12q24 Ataxin-2 Cytoplasmic microaggregates
SCA3 MJD 14q24.3-q31 Machado-Joseph disease Intranuclear inclusions, colocalization with the proteasome
protein 1
SCA4 SCA4 16q22.1 – No data
SCA5 SCA5 11p11-q11 – No data
SCA6 CACNA1A 19p13 Voltage-dependent Numerous cytoplasmic inclusions, in Purkinje cells, no ubiquitination
P/Q-type calcium channel
alpha-1A subunit
SCA7 SCA7 3p21.1-p12 Ataxin-7 Ubiquitinated intranuclear inclusions in several brain regions,
containing proteasome subunits
SCA8 SCA8 13q21 – No data
SCA9 – not assigned – No data
SCA10 SCA10 22q13 Ataxin-10 No data
SCA11 SCA11 15q14-q21.3 – No data
SCA12 SCA12 5q31-q33 – No inclusions
SCA13 SCA13 19q13.3-q13.4 – No data
SCA14 PRKCG 19q13.4-qter Protein kinase C gamma No inclusions
SCA15 SCA15 – – No data
SCA16 SCA16 8q22.1-q24.1 – No data
SCA17 TBP 6q27 TFIID Neuronal intranuclear inclusion bodies
SCA18 – reserved –
SCA19 – 1p21-q21 – No data
SCA20 – – – No data
SCA21 – reserved 7p21-15 – No data
SCA22 – 1p21-q23 – No data
SCA25 – – – No dataNeuropsychiatric Disease and Treatment 2005:1(2) 129
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begins as ataxic gait after age 40. The cause of the disorder
is a CAG repeat expansion in the respective gene in the
14q24.3-q31 position (Takiyama et al 1993; Sequeiros
1994). Igarashi et al (1996) found association of
intergenerational instability of the expanded CAG repeat in
Machado-Joseph Disease (MJD) with a CAG/CAA
polymorphism in the CAG repeat and a CGG/GGG
polymorphism at the 3´ end of the CAG array. Their results
strongly suggest that an interallelic interaction is involved
in the intergenerational instability of the expanded CAG
repeat. The expanded CAG repeats are less stable in paternal
transmission than in maternal transmission.
Ataxin-3 adopts a unique conformation when expressed
within the nucleus of transfected cells. This novel
conformation of intranuclear ataxin-3 is not due to
proteolysis, suggesting instead that association with nuclear
protein(s) alters the structure of full-length ataxin-3,
exposing the polyglutamine domain. This conformationally
altered ataxin-3 is bound to the nuclear matrix. The
pathologic form of ataxin-3 with an expanded polyglutamine
domain also associates with the nuclear matrix (Perez et al
1999). These data suggest that an early event in the
pathogenesis of SCA3/MJD may be an altered conformation
of ataxin-3 within the nucleus that exposes the
polyglutamine domain. The abnormally strong or aspecific
interactions of this protein may be the key to the disease.
However, intranuclear aggregations of ataxin-3 can also
be observed. Human disease tissue and in vitro models show
redistribution of the 26S proteasome complex into
polyglutamine aggregates. In neurons from SCA3 brain, the
proteasome is localized to intranuclear inclusion bodies
containing mutant ataxin-3. Inclusion formation is
dependent on the nuclear localization of the mutant protein
and occurs in special subnuclear structures recently
implicated in the regulation of cell death. Inhibitors of the
proteasome cause a repeat-length dependent increase in
aggregate formation (Chai et al 1999). These results suggest
a central role for protein misfolding in the pathogenesis and
that modulating proteasome activity is a potential approach
to altering the progression of the polyglutamine diseases.
Frameshift mutations in expanded CAG tracts of
ataxin-3 can generate polyalanine mutant proteins that also
form intranuclear inclusions. The frameshifts may more
likely occur in longer CAG repeats (Gaspar et al 2000).
The Drosophila model for this disease has led to some
new observations. The sensitivity of different cell types is
variable to the inclusion of the ataxin-3 protein, and neurons
seem to be especially susceptible (Warrick et al 1998).
Molecular chaperones Hsp70 and Hdj1 (the Drosophila
homolog of human HSP40) show substrate specificity to
polyglutamine proteins and alter the solubility of the mutant
polyglutamine protein, suppressing neurotoxicity (Chan et
al 2000).
Latest results indicate that ataxin-3 is a transcriptional
inhibitor. Interactions of ataxin-3 and other regulators of
histone acetylation and transcription (p300, CREB-binding
protein) have been detected (Li et al 2002).
SCA5
In a family descendant from the grandparents of President
Lincoln, Ranum et al (1994) mapped the gene of SCA5 to
the centromeric region of chromosome 11 by linkage to
DNA markers. The most dramatic examples of anticipation
occur with maternal transmission. There are several
3-generation examples of grandmothers having onsets
10–20 years later in life than their daughters, who in turn
had onsets 10–20 years later in life than their children.
Furthermore, all 4 cases of juvenile onset (10–18 years) are
instances of maternal inheritance.
SCA6
SCA6 was mapped by genomewide linkage analysis in 15
Japanese families with autosomal pure cerebellar ataxia
(Ishikawa et al 1997). CAG repeat arrays are translated
as polyglutamine tracts in the protein product, which is
the alpha (1A)-voltage-dependent calcium channel
(CACNA1A) (Zhuchenko et al 1997).
The calcium channel mRNA/protein containing the CAG
repeat/polyglutamine tract is most intensely expressed in
Purkinje cells of normal human brains. In SCA6 brains,
numerous oval or rod-shaped aggregates can be seen
exclusively in the cytoplasm of Purkinje cells. These
cytoplasmic inclusions are not ubiquitinated, which contrasts
with the neuronal intranuclear inclusions of other CAG
repeat/polyglutamine diseases. In cultured cells, formation
of perinuclear aggregates of the channel protein and
apoptotic cell death can be seen when transfected with full-
length CACNA1A coding an expanded polyglutamine tract.
It can be stated that the mechanism of neurodegeneration in
SCA6 is associated with cytoplasmic aggregations of the
alpha-1A calcium channel protein caused by a small CAG
repeat/polyglutamine expansion in CACNA1A (Ishikawa
et al 1999).
Genetic anticipation in case of these CAG repeat
expansions is not so trivial, some alleles seem to be very
stable (Ishikawa et al 1997). Point mutant allelic forms ofNeuropsychiatric Disease and Treatment 2005:1(2) 130
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SCA6 cause different neurologic disorders (as mentioned
above).
SCA7
SCA7 has a special clinical symptom: this is the only ataxia
associated with retinal degeneration (Froment et al 1937).
The pathogenic SCA7 CAG expansion was cloned by
RAPID (repeat analysis, pooled isolation, and detection)
from an archived DNA sample from an individual affected
with ataxia and retinal degeneration (Koob et al 1998).
Mice expressing mutant human ataxin-7 show nuclear
inclusions of ubiqutinated ataxin-7 protein that recruits
subunits of proteases and chaperons. Proteolitic cleavage
and transneuronal responses are likely to be involved in
pathogenesis (Yvert et al 2000).
In yeast 2-hybrid system, ataxin-7 interacts with CRX,
a nuclear transcription factor predominantly expressed in
retinal photoreceptor cells. Coimmunoprecipitation
experiments colocalized ataxin-7 with CRX in nuclear
aggregates. Polyglutamine-expanded ataxin-7 suppresses
CRX transactivation in transgenic retinas. SCA7 transgenic
mice faithfully recapitulate the process of retinal
degeneration observed in human SCA7 patients. Thus, the
specificity of the mutant protein can be explained by
interactions with specific partners of the ataxin-7 protein
(La Spada et al 2001).
Latest results in the research on interactive partners of
the protein show that ataxin-7 is a member of at least three
different complexes involved in the regulation of mammalian
chromatin structure. Ataxin-7 is an integral component of
SAGA-like complexes (SAGA in yeast contains the Gcn5
acetylase), the TATA-binding protein-free TAF-containing
complex (TFTC) and the SPT3-TAF9-GCN5 acetyl-
transferase complex (STAGA). A Zn-binding domain
potentially involved in protein–protein interactions of the
ataxin-7 protein was also identified. An interesting finding
is that the elongated polyglutamine domain does not affect
incorporation of ataxin-7 into the complexes (Helmlinger
et al 2004).
SCA8
SCA8 was identified by Koob et al (1999). It was mapped
to the 13q21 and was cloned using the RAPID technique.
SCA8 is also a CAG repeat disorder. Repeat length
contracts with paternal transmission, but expansion can be
observed in maternal transmission. The CAG repeat in the
mutant alleles is not translated into a polyglutamine tract,
but the CTG repeat in the complement strand is part of a
transcribed but not translated RNA. The gene organization
in this region is very complex: it is hypothesized that SCA8
RNA is an endogenous antisense, which is transcribed
through the first exon of the gene KLHL1 (Nemes et al 2000).
Thus, the SCA8 gene codes for an untranslated RNA
functioning as a gene regulator (Erdmann et al 2001).
The gene often contains CCG, CTA, CTC, CCA, or CTT
interruptions preceding the repeat region that may play a
role in reducing the penetrance of disease alleles (Moseley
et al 2000).
SCA8 repeat expansion can coexist with SCA1 and SCA6
repeats, and the protein product can act through the SCA6
coded calcium channel (Izumi et al 2003, Sulek et al 2003).
SCA10
SCA10 is determined by a gene which maps to the 22nd
chromosome (Zu et al 1999) and includes an ATTCT
pentanucleotide repeat region in the 9th
 intron of the gene
(Matsuura et al 2000). Mutant alleles contain expansion of
this repeat.
SCA14
The gene responsible for SCA14 ataxia was mapped to the
19q13.4-qter (Yamashita et al 2000). SCA14 type ataxia is
not attributable to trinucleotide repeat expansion (Brkanac
et al 2002) but to various mutations in the PRKCG (protein
kinase C gamma) gene which result in altering a highly
conserved residue in the cystein rich region of the respective
protein (Chen et al 2003).
SCA17
The SCA17 gene codes for the TATA-binding protein (TBP).
Elongated CAG repeats in the coding region cause this type
of ataxia (Koide et al 1999). Using anti-TBP and 1C2 (which
is used to identify polyglutamine tracts) antibodies, neuronal
intranuclear inclusion bodies can be observed in Purkinje
cells (Rolfs et al 2003). There is only a weak correlation
between the repeat number and the age of onset, but an
extremely expanded repeat region can cause very severe
phenotypes and early onset (Maltecca et al 2003).
Perspectives and potential therapy
Although molecular aspects of described ataxias are
intensively studied, we still need to gain more information
to be able to design a treatment of ataxia patients. One
possible way could be the inhibition proteases (eg, caspases)Neuropsychiatric Disease and Treatment 2005:1(2) 131
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that are involved in the formation of inclusion bodies from
the respective polyglutamine proteins. This task requires
extensive research of proteases that are specific for the given
type of SCA. Another approach to treatment could be
modulating proteosome activity. The observation that the
elongated form of ataxin-3 in inclusion bodies is colocalized
with the 26S proteosome complex (Chai et al 1999) implies
that the proteosome could have a major role in the
development of the disorder.
It is also proven that polyglutamine proteins need
molecular chaperons to gain their conformation, and in some
cases elongated polyglutamine tract containing proteins are
localized together with chaperons (eg, heatshock proteins)
(Cummings et al 1998). Research on the effect of altering
the level of specific chaperons could also be very informative
in designing a treatment for spinocerebellar ataxias.
The latest results indicate that oxidative stress may have
a role in the development of spinocerebellar ataxias. The
mutant form of ataxin-1, which contains the expanded poly-
glutamine tract, recruits Cu/Zn-superoxid dismutase into the
nucleus of HeLa cells and also decreases the activity of the
enzyme. This process exposes the cells to reactive oxygen
species (Kim et al 2003). Increasing superoxid dismutase
activity or reducing the level of reactive oxygen species may
also delay the development of the disorder.
Inhibition of phosphorylation of certain aminoacids
could also hinder the development of the disease by blocking
the molecular interactions of the expanded polyglutamine
domains (Emamian 2003).
In studying and understanding the pathomechanism and
molecular features of ataxias, models (mouse and
Drosophila) are going to be indispensable. In some types of
ataxias these have already been generated and are in use.
This is a great step compared with studies in cell lines,
because gaining in vivo data is very important in determining
the molecular interactions of ataxia-related proteins. The
aim is to gain a wide range of information in the molecular
and biochemical alterations in these disorders and to design
an effective therapy.
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